Related Experiment Video
Updated: Jul 3, 2026
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
microRNAs: a new frontier in kallikrein research
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto M5G 1L5, Canada. yousefg@smh.toronto.on.ca
Abstract:
microRNAs (miRNAs) are a recently discovered class of small non-coding RNAs that regulate gene expression. Rapidly accumulating evidence has revealed that miRNAs are associated with cancer. The human tissue kallikrein gene family is the largest contiguous family of proteases in the human genome, containing 15 genes. Many kallikreins have been reported as potential tumor markers. In this review, recent bioinformatics and experimental evidence is presented indicating that kallikreins are potential miRNA targets. The available experimental approaches to investigate these interactions and the potential diagnostic and therapeutic applications are also discussed. miRNAs represent a possible regulatory mechanism for controlling kallikrein expression at the post-transcriptional level. Many miRNAs were predicted to target kallikreins and a single miRNA can target more than one kallikrein. Recent evidence suggests that miRNAs can also exert 'quantitative' control of kallikreins by utilizing multiple targeting sites in the kallikrein mRNA. More research is needed to experimentally verify the in silico predictions and to investigate the possible role in tumor initiation and/or progression.
Insights
MicroRNAs (miRNAs) regulate gene expression and are linked to cancer. This review explores how miRNAs target kallikreins, potential tumor markers, offering insights into diagnostics and therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- miRNAs are increasingly associated with various cancers.
- The human tissue kallikrein (KLK) gene family comprises 15 protease genes, many implicated as tumor markers.
Purpose of the Study:
- To review current bioinformatics and experimental evidence on kallikreins as miRNA targets.
- To discuss methods for investigating miRNA-kallikrein interactions.
- To explore the diagnostic and therapeutic potential of these interactions in cancer.
Main Methods:
- Bioinformatic prediction of miRNA targeting kallikreins.
- Review of experimental validation studies.
- Analysis of kallikrein gene family structure and function.
Main Results:
- Numerous miRNAs are predicted to target kallikrein genes.
- A single miRNA can target multiple kallikreins.
- miRNAs can quantitatively control kallikrein expression via multiple mRNA binding sites.
Conclusions:
- miRNAs represent a post-transcriptional regulatory mechanism for kallikrein expression.
- miRNA-kallikrein interactions hold potential for cancer diagnostics and therapeutics.
- Further experimental validation is required to confirm in silico findings and elucidate roles in tumorigenesis.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs